HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masashi Mizokami Selected Research

Chronic Hepatitis (Chronic Active Hepatitis)

7/2022Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
1/2016Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B.
1/2013A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.
10/2012LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
1/2011Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray.
7/2009Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
11/2007[Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay].
11/2007Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.
9/2007Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life.
12/2006High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masashi Mizokami Research Topics

Disease

116Infections
01/2024 - 01/2000
49Chronic Hepatitis C
01/2021 - 10/2003
48Hepatocellular Carcinoma (Hepatoma)
02/2024 - 01/2000
39Chronic Hepatitis B
01/2024 - 01/2003
38Hepatitis B
01/2024 - 08/2004
31Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 06/2002
29Fibrosis (Cirrhosis)
10/2023 - 07/2003
28Hepatitis
01/2024 - 11/2003
24Liver Diseases (Liver Disease)
04/2024 - 01/2002
19Neoplasms (Cancer)
02/2024 - 09/2008
15Chronic Hepatitis (Chronic Active Hepatitis)
07/2022 - 06/2002
12COVID-19
01/2023 - 08/2020
12Hepatitis C
10/2020 - 01/2006
12Hemorrhage
01/2017 - 05/2005
11Carcinogenesis
03/2023 - 04/2007
10Disease Progression
01/2022 - 12/2004
6Inflammation (Inflammations)
04/2024 - 07/2008
6Liver Neoplasms (Liver Cancer)
03/2023 - 08/2002
6Lymphoma (Lymphomas)
01/2020 - 07/2009
6Virus Diseases (Viral Diseases)
01/2013 - 12/2002
5Hypertension (High Blood Pressure)
05/2021 - 01/2013
5Non-alcoholic Fatty Liver Disease
07/2018 - 07/2015
5Persistent Infection
10/2017 - 01/2002
5Anemia
03/2013 - 05/2005
5Massive Hepatic Necrosis
10/2012 - 05/2004
4Obesity
05/2021 - 04/2007
4Diverticular Diseases
10/2015 - 10/2014
4Hemolytic Anemia
03/2013 - 11/2010
4Coinfection
01/2012 - 04/2002
4Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011 - 10/2006
4Viremia
01/2011 - 10/2003
3Pneumonia (Pneumonitis)
01/2023 - 01/2021
3Diarrhea
01/2023 - 09/2008
3Hematologic Neoplasms (Hematological Malignancy)
08/2022 - 03/2011
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2015
3Fever (Fevers)
01/2022 - 09/2008
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2015 - 03/2014

Drug/Important Bio-Agent (IBA)

50InterferonsIBA
08/2022 - 12/2003
41Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2024 - 08/2002
38DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2002
34Ribavirin (Virazole)FDA LinkGeneric
07/2018 - 02/2005
33Antiviral Agents (Antivirals)IBA
08/2022 - 01/2003
23Hepatitis B e AntigensIBA
01/2019 - 01/2002
20RNA (Ribonucleic Acid)IBA
04/2024 - 08/2003
20Biomarkers (Surrogate Marker)IBA
02/2024 - 04/2011
20Proteins (Proteins, Gene)FDA Link
02/2024 - 12/2002
14Lamivudine (Epivir)FDA Link
01/2024 - 11/2003
13Alanine Transaminase (SGPT)IBA
04/2024 - 06/2002
12CytokinesIBA
01/2024 - 10/2003
12Carrier Proteins (Binding Protein)IBA
01/2024 - 01/2013
11AntigensIBA
01/2023 - 06/2004
10Rituximab (Mabthera)FDA Link
08/2022 - 07/2009
10AntibodiesIBA
04/2022 - 04/2007
10wisteria lectinIBA
05/2019 - 11/2014
9Polysaccharides (Glycans)IBA
02/2024 - 03/2009
9Transaminases (Aminotransferases)IBA
07/2009 - 08/2004
8NucleotidesIBA
01/2024 - 01/2006
8NucleosidesIBA
01/2024 - 02/2015
7entecavirFDA Link
01/2024 - 06/2011
7EnzymesIBA
12/2023 - 11/2007
7VaccinesIBA
08/2022 - 05/2006
7Monoclonal AntibodiesIBA
04/2022 - 03/2014
7SofosbuvirIBA
07/2018 - 11/2014
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 01/2013
5Interferon LambdaIBA
07/2022 - 05/2010
5sodium-bile acid cotransporterIBA
03/2020 - 05/2014
5ledipasvirIBA
01/2017 - 06/2015
5LectinsIBA
03/2014 - 01/2011
5Interferon-alpha (Interferon Alfa)IBA
03/2013 - 04/2005
4nasIBA
01/2024 - 07/2007
4HLA Antigens (Human Leukocyte Antigens)IBA
03/2023 - 01/2014
4Circular DNAIBA
01/2023 - 05/2004
4Therapeutic UsesIBA
06/2021 - 03/2007
4ChemokinesIBA
01/2021 - 01/2016
4sofosbuvir drug combination ledipasvirIBA
01/2021 - 06/2015
4ORALIT (ORS)IBA
11/2015 - 12/2013
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2015 - 10/2014
4SteroidsIBA
09/2015 - 07/2009
4Glycoproteins (Glycoprotein)IBA
03/2014 - 01/2011
4Inosine TriphosphataseIBA
03/2013 - 11/2010
4Complementary DNA (cDNA)IBA
10/2012 - 01/2006
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2011 - 10/2006
4acarboxyprothrombin (PIVKA)IBA
03/2009 - 07/2004
3Immunoglobulin G (IgG)IBA
04/2024 - 11/2007
3Tenofovir (Viread)FDA Link
01/2024 - 07/2022
3HLA-DPB1 antigen (HLA DPB1)IBA
12/2023 - 01/2012
3HLA-A Antigens (HLA-A)IBA
03/2023 - 01/2018
3Membrane Proteins (Integral Membrane Proteins)IBA
04/2022 - 01/2017
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2021 - 10/2020
3Nucleic AcidsIBA
10/2019 - 06/2004
3HLA-DP Antigens (HLA-DP)IBA
10/2017 - 01/2012
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2016 - 10/2014
3AlbuminsIBA
11/2016 - 11/2014
3Macrophage Colony-Stimulating FactorIBA
03/2016 - 03/2014
3Hyaluronic Acid (Hyaluronan)IBA
01/2016 - 10/2012
3mogamulizumabIBA
12/2015 - 03/2014

Therapy/Procedure

78Therapeutics
01/2024 - 01/2003
16Drug Therapy (Chemotherapy)
05/2021 - 09/2008
5Blood Transfusion (Blood Transfusions)
07/2015 - 01/2000
3Hematopoietic Stem Cell Transplantation
01/2024 - 03/2011